PRICE T ROWE ASSOCIATES INC /MD/
Position in RIGL — Rigel Pharmaceuticals Inc
CIK 80255
BALTIMORE, MD
Position in RIGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$591,220
+$270,634 QoQ
Shares Held
15,113
+27.5% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 156 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. RIGL ranks #198 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in RIGL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $591,220 | 15,113 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $320,586 | 11,856 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $446,888 | 10,434 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $263,044 | 9,285 | Shares | Defined | 2025-11-14 | |
| 2024-09-30 | $200,858 | 12,414 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $92,918 | 11,304 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $167,309 | 113,047 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $150,697 | 103,929 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $108,265 | 100,246 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $127,547 | 98,874 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $148,923 | 112,821 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $163,069 | 108,713 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $128,281 | 108,713 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $190,181 | 168,302 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $248,474 | 83,102 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $144,308 | 54,456 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $210,380 | 57,956 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $246,715 | 56,847 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $150,315 | 43,952 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $40,642 | 11,612 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $30,028 | 12,512 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $22,896 | 12,512 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $6,146,195 | 3,939,869 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||